LifeMD, Inc.
LFMD
$3.90
-$0.19-4.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 233.84M | 192.46M | 185.56M | 176.38M | 154.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 233.84M | 192.46M | 185.56M | 176.38M | 154.82M |
| Cost of Revenue | 29.51M | 30.28M | 27.89M | 25.48M | 21.44M |
| Gross Profit | 204.34M | 162.18M | 157.67M | 150.89M | 133.38M |
| SG&A Expenses | 186.41M | 152.20M | 150.76M | 147.55M | 139.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 10.38M | 9.37M | 8.57M | 7.59M | 7.56M |
| Total Operating Expenses | 236.39M | 199.88M | 195.00M | 188.07M | 175.23M |
| Operating Income | -2.54M | -7.42M | -9.44M | -11.69M | -20.40M |
| Income Before Tax | -5.23M | -10.73M | -11.90M | -14.01M | -22.58M |
| Income Tax Expenses | 183.00K | 534.60K | 598.00K | 598.00K | 598.00K |
| Earnings from Continuing Operations | -5.41 | -11.27 | -12.50 | -14.61 | -23.18 |
| Earnings from Discontinued Operations | 21.03M | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.27M | -1.60M | -1.22M | -961.30K | -548.90K |
| Net Income | 14.35M | -10.55M | -11.40M | -13.26M | -21.41M |
| EBIT | -2.54M | -7.42M | -9.44M | -11.69M | -20.40M |
| EBITDA | -845.70K | -6.60M | -8.76M | -11.10M | -19.91M |
| EPS Basic | 0.24 | -0.31 | -0.34 | -0.39 | -0.60 |
| Normalized Basic EPS | -0.08 | -0.17 | -0.20 | -0.23 | -0.36 |
| EPS Diluted | 0.23 | -0.32 | -0.35 | -0.40 | -0.60 |
| Normalized Diluted EPS | -0.08 | -0.18 | -0.20 | -0.23 | -0.36 |
| Average Basic Shares Outstanding | 180.50M | 174.92M | 170.78M | 167.66M | 163.77M |
| Average Diluted Shares Outstanding | 182.94M | 177.37M | 173.23M | 170.11M | 163.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 21.64% | -29.45% | -27.25% | -23.43% | -14.51% |